Exhibit 99.1
image_0.jpg
Investor Relations:
Brian Norris
Senior Vice President of Finance and Investor Relations
bnorris@evolvtechnology.com
Evolv Technology Reports Second Quarter Financial Results

Q2 Revenue of $25.5 million, up 29% year-over-year
Q2 Ending ARR1 of $88.9 million, up 64% year-over-year
Q2 Ending RPO2 of $262.9 million, up 33% year-over-year
Q2 Ending Evolv Express® subscriptions of 5,323, up 57% year-over-year
Waltham, Massachusetts – August 8, 2024 – Evolv Technology (NASDAQ: EVLV), a leading security technology company pioneering AI-based screening designed to help create safer experiences, today announced financial results for the quarter ended June 30, 2024.
Results for the Second Quarter of 2024
Total revenue for the second quarter of 2024 was $25.5 million, an increase of 29% compared to $19.8 million for the second quarter of 2023. Annual Recurring Revenue (“ARR”)1 was $88.9 million at the end of second quarter of 2024, an increase of 64% compared to $54.3 million at the end of the second quarter of 2023. Net income for the second quarter of 2024 was $3.5 million, or $0.02 per basic and diluted share, compared to net loss of $(66.8) million, or $(0.45) per basic and diluted share, in the second quarter of 2023. Adjusted earnings (loss)3 for the second quarter of 2024 was $(11.1) million, or $(0.06) per diluted share, compared to adjusted earnings (loss)3 of $(14.3) million, or $(0.10) per diluted share, for the second quarter of 2023. Adjusted EBITDA3 for the second quarter of 2024 was $(7.9) million compared to $(13.8) million in the second quarter of 2023. As of June 30, 2024, the Company had cash, cash equivalents, marketable securities, and restricted cash of $56.7 million and no debt.
Results for the First Six Months of 2024
Total revenue for the six months ended June 30, 2024 was $47.2 million, an increase of 23% compared to $38.4 million for the six months ended June 30, 2023. Net loss for the six months ended June 30, 2024 was $(8.2) million, or $(0.05) per basic and diluted share, compared to $(95.4) million, or $(0.65) per basic and diluted share, in the six months ended June 30, 2023. Adjusted earnings (loss)3 for the six months ended June 30, 2024 was $(24.2) million, or $(0.16) per diluted share, compared to adjusted earnings (loss)3 of $(31.2) million, or $(0.21) per diluted share, for the six months ended June 30, 2023. Adjusted EBITDA3 for the six months ended June 30, 2024 was $(18.6) million compared to $(29.3) million in the six months ended June 30, 2023.
The following table summarizes the breakdown of recurring and non-recurring revenue4 for each period presented:
Three Months Ended
June 30,
Six Months Ended
June 30,
20242023% Change20242023% Change
Recurring revenue$21,249 $11,689 82 %$40,630 $20,764 96 %
Non-recurring revenue4,291 8,136 (47)%6,578 17,642 (63)%
Total revenue$25,540 $19,825 29 %$47,208 $38,406 23 %



The following table summarizes operating cash flows for each period presented:
Three Months Ended
June 30,
Six Months Ended
June 30,
2024202320242023
Net loss$3,462 $(66,754)$(8,182)$(95,363)
Non-cash expense(12,264)54,225 (10,611)68,230 
Changes in operating assets and liabilities(13,077)7,208 (19,169)18,378 
Net cash used in operating activities$(21,879)$(5,321)$(37,962)$(8,755)
Company Comments on Outlook for 2024
The Company today commented on its business outlook for 2024. The Company's outlook is based on the current indications for its business, which may change at any time.

Estimate ($ in millions)
Issued May 9, 2024
Issued August 8, 2024
Total Revenue~$100Reaffirmed
ARR1 (ARR) at 12/31/24
~$100Reaffirmed
Adjusted Gross Margin3
~60%Reaffirmed
Adjusted EBITDA3
Improve by 40%+Reaffirmed
Company to Host Live Conference Call and Webcast
The Company’s management team plans to host a live conference call and webcast at 4:30 p.m. Eastern Time today to discuss the financial results as well as management’s outlook for the business and other matters. The conference call may be accessed in the United States by dialing +1.877.692.8955 and using access code 825879. The conference call may be accessed outside of the United States by dialing +1.234.720.6979 and using the same access code. The conference call will be simultaneously webcast on the Company’s investor relations website, which can be accessed at http://ir.evolvtechnology.com. The press release with the financial results will be available on the Company’s website prior to the conference call. A replay of the conference call will be available for a period of 30 days by dialing +1.866.207.1041 or +1.402.970.0847 and using access code 8674340 or by accessing the webcast replay on the Company’s investor relations website at http://ir.evolvtechnology.com.

About Evolv Technology
Evolv Technology (NASDAQ: EVLV) uses advanced sensors, artificial intelligence powered software, and cloud services to reliably detect firearms, improvised explosives, and certain types of knives while ignoring many harmless items such as cell phones and keys. Its solutions and services are designed to capture valuable visitor data customers can leverage to inform their security operations, while providing end-users with an approachable and non-intrusive security experience. Evolv has digitally transformed the gateways in many places where people gather by enabling seamless integration combined with powerful analytics and insights. Evolv’s advanced systems have scanned more than a billion people since 2019. Evolv has been awarded the U.S. Department of Homeland Security (DHS) SAFETY Act Designation as a Qualified Anti-Terrorism Technology (QATT) as well as the Security Industry Association (SIA) New Products and Solutions (NPS) Award in the Law Enforcement/Public Safety/Guarding Systems category, as well as Sport Business Journal’s (SBJ) awards for “Best In Fan Experience Technology” and “Best In Sports Technology”. Evolv®, Evolv Express®, Evolv Insights®, Evolv Cortex AI®, and Evolv Visual Gun Detection™ are registered trademarks or trademarks of Evolv Technologies, Inc. in the United States and other jurisdictions. For more information, visit https://evolvtechnology.com.
1 We define Annual Recurring Revenue, or ARR, as subscription revenue and the recurring service revenue related to purchase subscriptions for the final month of the quarter normalized to a one-year period. Our calculation of ARR is not adjusted for the impact of any known or projected future events (such as customer cancellations, upgrades or downgrades, or price increases or decreases) that may cause any such contract not to be renewed on its existing terms. In addition, the amount of actual revenue that we recognize over any 12-month period is likely to differ from ARR at the beginning of that period, sometimes significantly. This may occur due to new bookings, cancellations, upgrades, downgrades or other changes in pending renewals, as well as the effects of professional services revenue and acquisitions or divestitures. As a result, ARR should be viewed independently of, and not as a substitute for or forecast of, revenue and deferred revenue. Our calculation of ARR may differ from similarly titled metrics presented by other companies.



2 We define Remaining Performance Obligation, or RPO, as estimated revenues expected to be recognized in the future related to performance obligations that are unsatisfied or partially satisfied as of the end of the quarter.
3 Non-GAAP Financial Measures In this press release, the Company’s adjusted gross profit (loss), adjusted gross margin, adjusted operating expenses, adjusted operating income (loss), adjusted EBITDA, adjusted earnings (loss), and adjusted earnings per diluted share are not presented in accordance with generally accepted accounting principles (GAAP) and are not intended to be used in lieu of GAAP presentations of results of operations. Adjusted gross profit and adjusted gross margin exclude one-time expenses, stock-based compensation expense, and amortization of capitalized stock-based compensation which management believes provides a more meaningful representation of contribution margin. Adjusted operating expenses is defined as operating expenses less one-time expenses, stock-based compensation expense, amortization of capitalized stock-based compensation, and loss on impairment of lease equipment which management believes provides a more meaningful representation of on-going operating expense levels. Adjusted EBITDA is defined as net income (loss) plus depreciation and amortization, share-based compensation, interest expense (income), loss on extinguishment of debt, change in fair value of contingent earn-out liability, change in fair value of contingently issuable common stock liability, change in fair value of public warrant liability, loss on impairment of lease equipment, and certain other one-time expenses. Adjusted earnings (loss) is defined as net income (loss) plus stock-based compensation, amortization of capitalized stock-based compensation, loss on extinguishment of debt, change in fair value of contingent earn-out liability, change in fair value of contingently issuable common stock liability, change in fair value of public warrant liability, loss on impairment of lease equipment, and certain other one-time expenses. Management presents non-GAAP financial measures because it considers them to be important supplemental measures of performance. Management uses non-GAAP financial measures for planning purposes, including analysis of the Company's performance against prior periods, the preparation of operating budgets and to determine appropriate levels of operating and capital investments. Management also believes non-GAAP financial measures provide additional insight for analysts and investors in evaluating the Company's financial and operating performance. However, non-GAAP financial measures have limitations as an analytical tool and are not intended to be an alternative to financial measures prepared in accordance with GAAP. We intend to provide non-GAAP financial measures as part of our future earnings discussions and, therefore, the inclusion of non-GAAP financial measures will provide consistency in our financial reporting. Investors are encouraged to review the reconciliation of these non-GAAP measures to their most directly comparable GAAP financial measures included in this press release. The Company is unable to provide a reconciliation of Adjusted Gross Margin to GAAP Gross Margin and Adjusted EBITDA to Net Income (Loss), each measure's most directly comparable GAAP financial measure, on a forward-looking basis without unreasonable effort, because items that impact these GAAP financial measures are not within the Company’s control and/or cannot be reasonably predicted. These items may include, but are not limited to, predicting forward-looking share-based compensation, changes in the fair value of derivative liabilities, changes in the fair value of contingent earn out liabilities, changes in the fair value of contingently issuable common stock liabilities and changes in fair value of public warrant liabilities. Such information may have a significant, and potentially unpredictable, impact on the Company’s future financial results.
4 Recurring revenue includes the recurring portion of revenue associated with pure subscription contracts and hardware purchase subscription contracts. Non-recurring revenue includes revenue that is one-time in nature, such as product revenue, shipping revenue, and revenue from installation, training, and professional services.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All statements contained in this press release and related presentation materials other than statements of historical facts, including without limitation statements regarding our ability to meet our 2024 guidance for revenue, ARR, adjusted gross margin, and adjusted EBITDA, our estimates for cash and cash equivalents for fiscal year 2024, our results of operations and financial position, business strategy, plans and prospects, our relationship with significant manufacturers and suppliers, our ability to obtain new customers and retain existing customers, existing and prospective products, the potential benefits of our ongoing transition to a pure subscription model, timing and likelihood of success, macroeconomic and market trends, our expectations regarding any outcomes and impact of any legal proceedings, government investigation or enforcement action (such as the current investigations by the FTC and the SEC), and plans and objectives of management for future operations and results are forward-looking statements. Words such as “believe” “may,” “will,” “expect,” “should,” “could,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “project,” “plan,” “target,” “forecast”, “is/are likely to” or the negative of these terms or other similar expressions are intended to identify forward-looking statements, though not all forward-looking statements use these words or expressions. The forward-looking statements in this press release and related presentation materials are only predictions. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition and results of operations. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, the following: relating to our history of losses and ability to reach profitability; our reliance on reseller partners to generate a growing portion of our revenue; expectations regarding the Company’s strategies and future financial performance, including its future business plans or objectives,



prospective performance and opportunities and competitors, revenues, products and services, pricing, operating expenses, market trends, liquidity, cash flows and uses of cash, capital expenditures; the Company’s reliance on third party contract manufacturing and distribution, and a global supply chain; the Company recognizes a substantial portion of its revenue ratably over the term of its agreements, and, as a result, downturns or upturns in sales may not be immediately reflected in its operating results; the rate of innovation required to maintain competitiveness in the markets in which the Company competes; the competitiveness of the market in which the Company competes; the failure of our products to detect threats could result in injury or loss of life, which could harm our brand, reputation, and results of operations; the loss of designation of our Evolv Express® system as a Qualified Anti-Terrorism Technology under the Homeland Security SAFETY Act; risks related to our business model, which is predicated, in part, on building a customer base that will generate a recurring stream of revenues through the sale of our subscription contracts; the ability for the Company to obtain, maintain, protect and enforce the Company’s intellectual property rights and use of “open source” software; the concentration of the Company’s revenues on a single solution; the Company’s ability to timely design, produce and launch its solutions, the Company’s ability to invest in growth initiatives and pursue acquisition opportunities; the limited liquidity and trading of the Company’s securities; risks related to existing and changing tax laws; geopolitical risk and changes in applicable laws or regulations; the possibility that the Company may be adversely affected by other economic, business, and/or competitive factors; operational risk; risks related to material weaknesses in our internal control over financial reporting and our remediation plans; risks related to increasing attention to and evolving expectations for, environmental, social, and governance initiatives; the impact of fluctuating general economic and market conditions and reductions in spending; the need for additional capital to support business growth, which might not be available on acceptable terms, if at all; and litigation and regulatory enforcement risks, including the diversion of management time and attention and the additional costs and demands on resources. These and other important factors discussed under the caption “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2023 filed with the Securities and Exchange Commission ("SEC") on February 29, 2024, as any such factors may be updated from time to time in our other filings with the SEC, including the Quarterly Report on Form 10-Q for the quarter ended June 30, 2024. The forward-looking statements in this press release and related presentation materials are based upon information available to us as of the date hereof, and while we believe such information forms a reasonable basis for such statements, it may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements.
You should review this press release and the documents that we reference in this press release and related presentation materials with the understanding that our actual future results, levels of activity, performance and achievements may be materially different from what we expect. We qualify all of our forward-looking statements by these cautionary statements. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained in this press release and related presentation materials, whether as a result of any new information, future events or otherwise.



EVOLV TECHNOLOGY
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
(In thousands, except share and per share data)
(Unaudited)
Three Months Ended
June 30,
Six Months Ended
June 30,
2024202320242023
Revenue:
Product revenue$2,044 $7,243 $2,647 $15,997 
Subscription revenue15,903 7,964 30,406 14,430 
Service revenue5,553 3,905 10,937 6,691 
License fee and other revenue2,040 713 3,218 1,288 
Total revenue25,540 19,825 47,208 38,406 
Cost of revenue:
Cost of product revenue3,149 7,722 5,926 18,300 
Cost of subscription revenue6,436 3,406 12,215 5,757 
Cost of service revenue1,311 1,014 2,522 1,597 
Cost of license fee and other revenue172 270 301 574 
Total cost of revenue11,068 12,412 20,964 26,228 
Gross profit14,472 7,413 26,244 12,178 
Operating expenses:
Research and development5,722 6,395 11,927 11,784 
Sales and marketing16,892 13,613 32,897 26,417 
General and administrative14,185 10,874 26,025 19,800 
Loss from impairment of property and equipment— 157 — 294 
Total operating expenses36,799 31,039 70,849 58,295 
Loss from operations(22,327)(23,626)(44,605)(46,117)
Other income (expense), net:
Interest expense— — — (654)
Interest income681 1,853 1,766 2,806 
Other income (expense), net(39)(22)(67)(3)
Loss on extinguishment of debt— — — (626)
Change in fair value of contingent earn-out liability16,514 (28,113)23,413 (31,431)
Change in fair value of contingently issuable common stock liability3,747 (5,095)4,274 (5,837)
Change in fair value of public warrant liability4,886 (11,751)7,037 (13,501)
Total other income (expense), net25,789 (43,128)36,423 (49,246)
Net income (loss)$3,462 $(66,754)$(8,182)$(95,363)
Net income (loss) attributable to common stockholders – basic and diluted$3,421 $(66,754)$(8,182)$(95,363)
Weighted average common shares outstanding
Basic156,473,080148,882,160154,774,899147,664,534
Diluted171,563,943148,882,160154,774,899147,664,534
Net income (loss) per share
Basic$0.02 $(0.45)$(0.05)$(0.65)
Diluted$0.02 $(0.45)$(0.05)$(0.65)
Net income (loss)$3,462 $(66,754)$(8,182)$(95,363)
Other comprehensive income (loss)
Cumulative translation adjustment(17)11 (33)
Total other comprehensive income (loss)(17)11 (33)
Total comprehensive income (loss)$3,470 $(66,771)$(8,171)$(95,396)



EVOLV TECHNOLOGY
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per share data)
(Unaudited)
June 30, 2024December 31, 2023
Assets
Current assets:
Cash and cash equivalents$35,698 $67,162 
Restricted cash— 275 
Marketable securities20,757 51,289 
Accounts receivable, net36,428 22,611 
Inventory18,604 9,507 
Current portion of contract assets1,690 3,707 
Current portion of commission asset4,810 4,339 
Prepaid expenses and other current assets19,912 16,954 
Total current assets137,899 175,844 
Restricted cash, noncurrent275 — 
Contract assets, noncurrent144 451 
Commission asset, noncurrent7,128 7,107 
Property and equipment, net120,045 112,921 
Operating lease right-of-use assets2,161 1,195 
Other assets865 1,202 
Total assets$268,517 $298,720 
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable$5,574 $17,400 
Accrued expenses and other current liabilities15,913 15,578 
Current portion of deferred revenue56,168 47,677 
Current portion of operating lease liabilities1,754 1,391 
Total current liabilities79,409 82,046 
Deferred revenue, noncurrent23,655 23,813 
Operating lease liabilities, noncurrent566 — 
Contingent earn-out liability5,706 29,119 
Contingently issuable common stock liability2,256 6,530 
Public warrant liability3,852 10,889 
Total liabilities115,444 152,397 
Stockholders’ equity:
Preferred stock, $0.0001 par value; 100,000,000 authorized at June 30, 2024 and December 31, 2023; no shares issued and outstanding at June 30, 2024 and December 31, 2023
— — 
Common stock, $0.0001 par value; 1,100,000,000 shares authorized at June 30, 2024 and December 31, 2023; 157,474,122 and 151,310,080 shares issued and outstanding at June 30, 2024 and December 31, 2023, respectively
16 15 
Additional paid-in capital459,745 444,825 
Accumulated other comprehensive loss(42)(53)
Accumulated deficit(306,646)(298,464)
Stockholders’ equity153,073 146,323 
Total liabilities and stockholders’ equity$268,517 $298,720 



EVOLV TECHNOLOGY
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)
Six Months Ended
June 30,
20242023
Cash flows from operating activities:
Net loss$(8,182)$(95,363)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization7,442 4,087 
Write-off of inventory and change in inventory reserve1,725 337 
Loss from impairment of property and equipment— 294 
Stock-based compensation13,834 11,732 
Non-cash interest expense— 22 
Amortization (accretion) of premium (discount) on marketable securities, net of change in accrued interest181 (242)
Non-cash lease expense728 432 
Change in allowance for expected credit losses203 173 
Loss on extinguishment of debt— 626 
Change in fair value of earn-out liability(23,413)31,431 
Change in fair value of contingently issuable common stock(4,274)5,837 
Change in fair value of public warrant liability(7,037)13,501 
Changes in operating assets and liabilities
Accounts receivable(14,020)(646)
Inventory(10,354)5,080 
Commission assets(492)(1,258)
Contract assets2,324 (1,184)
Other assets337 (43)
Prepaid expenses and other current assets(2,958)580 
Accounts payable(1,653)(7,409)
Deferred revenue8,333 24,113 
Accrued expenses and other current liabilities79 (342)
Operating lease liability(765)(513)
Net cash used in operating activities(37,962)(8,755)
Cash flows from investing activities:
Development of internal-use software(3,408)(1,599)
Purchases of property and equipment(21,092)(33,173)
Proceeds from sale of property and equipment— 60 
Purchases of marketable securities(14,567)(29,405)
Proceeds from maturities of marketable securities44,918 — 
Net cash provided by (used in) investing activities5,851 (64,117)
Cash flows from financing activities:
Proceeds from exercise of stock options636 344 
Proceeds from long-term debt— 1,876 
Repayment of principal on long-term debt— (31,876)
Payment of debt issuance costs and prepayment penalty— (332)
Net cash provided by (used in) financing activities636 (29,988)
Effect of exchange rate changes on cash and cash equivalents11 (33)
Net decrease in cash, cash equivalents and restricted cash(31,464)(102,893)
Cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at beginning of period67,437 230,058 
Cash, cash equivalents and restricted cash at end of period$35,973 $127,165 



EVOLV TECHNOLOGY
SUMMARY OF KEY OPERATING STATISTICS
(Unaudited)
Three Months Ended or as of,
($ in thousands)March 31,
2023
June 30,
2023
September 30,
2023
December 31,
2023
March 31,
2024
June 30,
2024
New customers61 74 70 75 53 84 
Annual recurring revenue$42,021 $54,339 $65,774 $74,989 $82,511 $88,864 
Recurring revenue$9,075 $11,689 $14,377 $17,350 $19,381 $21,249 
Remaining performance obligation$161,813 $198,296 $221,126 $240,513 $254,070 $262,947 
Net additions520 599 628 491 377 441 
Ending deployed units2,787 3,386 4,014 4,505 4,882 5,323 

EVOLV TECHNOLOGY
RECONCILIATION OF GAAP OPERATING EXPENSES TO ADJUSTED OPERATING EXPENSES
(In thousands)
(Unaudited)

Three Months Ended,
March 31,
2023
June 30,
2023
September 30,
2023
December 31,
2023
March 31,
2024
June 30,
2024
Operating expenses, GAAP$27,256 $31,039 $31,629 $32,167 $34,050 $36,799 
Stock-based compensation(4,898)(6,505)(5,454)(6,711)(6,272)(7,251)
Loss on impairment of lease equipment(137)(157)(28)— — — 
Other one-time expenses(53)(683)(945)(535)(476)(3,011)
Adjusted operating expenses$22,168 $23,694 $25,202 $24,921 $27,302 $26,537 




EVOLV TECHNOLOGY
RECONCILIATION OF GAAP GROSS PROFIT TO ADJUSTED GROSS PROFIT, GAAP GROSS MARGIN TO ADJUSTED GROSS MARGIN AND GAAP OPERATING INCOME (LOSS) TO ADJUSTED OPERATING INCOME (LOSS)
(In thousands)
(Unaudited)
Three Months Ended
June 30,
Six Months Ended
June 30,
2024202320242023
Revenue$25,540 $19,825 $47,208 $38,406 
Cost of revenue11,068 12,412 20,964 26,228 
Gross profit, GAAP14,472 7,413 26,244 12,178 
Stock-based compensation173 184 311 329 
Amortization of capitalized stock-based compensation15 11 29 21 
Other one-time expenses106 — 1,310 — 
Adjusted gross profit$14,766 $7,608 $27,894 $12,528 
Gross margin %56.7 %37.4 %55.6 %31.7 %
Adjusted gross margin %57.8 %38.4 %59.1 %32.6 %

Three Months Ended
June 30,
Six Months Ended
June 30,
2024202320242023
Operating loss, GAAP$(22,327)$(23,626)$(44,605)$(46,117)
Stock-based compensation7,424 6,689 13,834 11,732 
Amortization of capitalized stock-based compensation15 11 29 21 
Loss on impairment of lease equipment— 157 — 294 
Other one-time expenses3,117 683 4,797 736 
Adjusted operating loss$(11,771)$(16,086)$(25,945)$(33,334)




EVOLV TECHNOLOGY
RECONCILIATION OF GAAP NET INCOME (LOSS) TO ADJUSTED EBITDA
(In thousands)
(Unaudited)
Three Months Ended
June 30,
Six Months Ended
June 30,
2024202320242023
Net income (loss)$3,462 $(66,754)$(8,182)$(95,363)
Depreciation & amortization3,968 2,272 7,442 4,087 
Stock-based compensation7,424 6,689 13,834 11,732 
Interest expense (income)(681)(1,853)(1,766)(2,152)
Loss on extinguishment of debt— — — 626 
Change in fair value of contingent earn-out liability(16,514)28,113 (23,413)31,431 
Change in fair value of contingently issuable common stock liability(3,747)5,095 (4,274)5,837 
Change in fair value of public warrant liability(4,886)11,751 (7,037)13,501 
Loss on impairment of lease equipment— 157 — 294 
Other one-time expenses3,117 683 4,797 736 
Adjusted EBITDA$(7,857)$(13,847)$(18,599)$(29,271)
EVOLV TECHNOLOGY
RECONCILIATION OF GAAP NET INCOME (LOSS) TO ADJUSTED EARNINGS (LOSS)
(In thousands, except share and per share data)
(Unaudited)
Three Months Ended
June 30,
Six Months Ended
June 30,
2024202320242023
Net income (loss)$3,462 $(66,754)$(8,182)$(95,363)
Stock-based compensation7,424 6,689 13,834 11,732 
Amortization of capitalized stock-based compensation15 11 29 21 
Loss on extinguishment of debt— — — 626 
Change in fair value of contingent earn-out liability(16,514)28,113 (23,413)31,431 
Change in fair value of contingently issuable common stock liability(3,747)5,095 (4,274)5,837 
Change in fair value of public warrant liability(4,886)11,751 (7,037)13,501 
Loss on impairment of lease equipment— 157 — 294 
Other one-time expenses3,117 683 4,797 736 
Adjusted loss$(11,129)$(14,255)$(24,246)$(31,185)
Weighted average common shares outstanding – diluted171,563,943 148,882,160 154,774,899 147,664,534 
Adjusted loss per share – diluted$(0.06)$(0.10)$(0.16)$(0.21)